L20
Conditions
Interventions
Group 1: Routine treatment of atopic dermatitis at the Department and Outpatient Clinic of Dermatology and Allergology with documentation at six visits every three months:
a) Completion of a short med
Sponsors
Almirall S.A.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosed atopic dermatitis with systemic treatment at the Department and Outpatient Clinic of Dermatology and Allergology. Information and written informed consent to voluntarily participate in the study.
Exclusion criteria
Exclusion criteria: Language barriers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Which types of treatment trajectories can be identified in atopic dermatitis in relation to individual influencing factors? Can standardized 3D whole-body imaging contribute to the assessment of disease severity and treatment progression in atopic dermatitis? Which environmental, psychological, demographic, and other factors influence the severity of atopic dermatitis and the patients’ quality of life during the course of treatment? Can future predictive markers for treatment progression be identified retrospectively? Which factors influence the course of treatment in atopic dermatitis? What is the relationship between the highest recorded peak disease value (e.g., Peak EASI) used to determine disease severity in atopic dermatitis and the subsequent therapy and treatment concept? | — |
Countries
Germany
Contacts
Public ContactAlexander Zink
Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein
Outcome results
None listed